AbCellera Biologics(ABCL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABCL AbCellera Biologics

Market Closed 09-18 16:00:00 EDT

12.63

-0.10

-0.79%

盘后12.70

+0.07+0.54%

19:59 EDT

High12.96	Low12.37	Vol5.44M
Open12.73	D1 Closing12.73	Amplitude4.63%
Mkt Cap4.09B	Tradable Cap2.79B	Total Shares324.00M
T/O68.41M	T/O Rate2.46%	Tradable Shares221.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABCL","market":"US","secType":"STK","nameCN":"AbCellera Biologics","latestPrice":12.63,"timestamp":1789761600000,"preClose":12.73,"halted":0,"volume":5438252,"hourTrading":{"tag":"盘后","latestPrice":12.6986,"preClose":12.63,"latestTime":"19:59 EDT","volume":170480,"amount":2153445.6643,"timestamp":1789775997250,"change":0.0686,"changeRate":0.005432,"amplitude":0.011876},"delay":0,"changeRate":-0.007855459544383318,"floatShares":221000000,"shares":324000000,"eps":-0.545545,"marketStatus":"Market Closed","change":-0.1,"latestTime":"09-18 16:00:00 EDT","open":12.73,"high":12.96,"low":12.37,"amount":68411643.943424,"amplitude":0.046347,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.545545,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"listingDate":1607662800000,"exchange":"NASDAQ","adjPreClose":12.73,"preHourTrading":{"tag":"盘前","latestPrice":12.89,"preClose":12.73,"latestTime":"09:29 EDT","volume":51531,"amount":663846.2008529999,"timestamp":1789738199999,"change":0.16,"changeRate":0.012569,"amplitude":0.043205},"postHourTrading":{"tag":"盘后","latestPrice":12.6986,"preClose":12.63,"latestTime":"19:59 EDT","volume":170480,"amount":2153445.6643,"timestamp":1789775997250,"change":0.0686,"changeRate":0.005432,"amplitude":0.011876},"volumeRatio":1.081372857518657,"impliedVol":0.8931,"impliedVolPercentile":0.2271},"requestUrl":"/m/hq/s/ABCL/tweets","defaultTab":"tweets","newsList":[{"id":"2668966649","title":"AbCellera Biologics call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2668966649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668966649?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:45","pubTimestamp":1789659911,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in AbCellera (ABCL) Biologics with 9,247 calls trading, 4x expected, and implied vol increasing over 10 points to 88.1...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-biologics-call-volume-above-normal-and-directionally-bullish-thefly-news-6?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-biologics-call-volume-above-normal-and-directionally-bullish-thefly-news-6?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABCL","BK4535","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668337689","title":"AbCellera to present Phase 2 Data for ABCL635 at IMS Congress on Menopause","url":"https://stock-news.laohu8.com/highlight/detail?id=2668337689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668337689?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:10","pubTimestamp":1789589409,"startTime":"0","endTime":"0","summary":"AbCellera (ABCL) “announced an upcoming oral presentation of Phase 2 data on ABCL635 at the International Menopause Society 20th World Congress on ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-to-present-phase-2-data-for-abcl635-at-ims-congress-on-menopause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-to-present-phase-2-data-for-abcl635-at-ims-congress-on-menopause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","ABCL","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668331669","title":"AbCellera to Present Phase 2 Abcl635 Data for Menopause Hot Flashes at IMS World Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2668331669","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668331669?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:06","pubTimestamp":1789589166,"startTime":"0","endTime":"0","summary":"AbCellera to present Phase 2 ABCL635 data for menopause hot flashes at IMS World Congress 2026Abcellera flagged upcoming Phase 2 data for ABCL635, a non-hormonal antibody for menopausal hot flashes, a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL4c4PXN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABCL","BK4121","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667723621","title":"AbCellera Biologics call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2667723621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667723621?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:10","pubTimestamp":1789499424,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in AbCellera (ABCL) Biologics with 5,617 calls trading, 1.1x expected, and implied vol increasing over 1 point to 81.3...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-biologics-call-volume-above-normal-and-directionally-bullish-thefly-news-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-biologics-call-volume-above-normal-and-directionally-bullish-thefly-news-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4121","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849535","title":"AbCellera to Present at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849535","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849535?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:06","pubTimestamp":1788379602,"startTime":"0","endTime":"0","summary":"AbCellera to present at Cantor Global Healthcare ConferenceAbCellera will present at the Cantor Global Healthcare Conference on Sept. 9, 2026.Disclaimer:This news brief was created by Public Technolog","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLGl90Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4535","ABCL"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1139190275","title":"Movement Alert｜AbCellera Biologics Falls 8.02% in Regular Trading, Life Sciences Sector Broadly Under Pressure Post Dilutive Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=1139190275","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139190275?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934627,"startTime":"0","endTime":"0","summary":"On August 29, AbCellera Biologics fell 8.02% in regular trading, trading at $11.395/share, with turnover of $33.19 million.The decline came amid broad-based weakness across the Life Sciences Tools &...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"AbCellera Falls After $200M Dilutive Offering","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662754748","title":"U.S. Small Caps Finish Mixed as AbCellera Biologics Leads, Bath & Body Works Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2662754748","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662754748?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:21","pubTimestamp":1787689260,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies were mixed Tuesday, as the Russell 2000 Index added 0.5%, and the S&P Small Cap 600 Index was unchanged.Among companies with a market value of $1 billion to $6.7 billion, AbCellera Biologics Inc. was the best performer during the session, surging 18%, followed by Inhibrx Biosciences Inc., which surged 17%. Generate Biomedicines Inc. shares surged 15%, Resolute Holdings Management surged 12%, and shares of Nayax Ltd. surged 12%.Bath & Body Works Inc. was the biggest laggard, dropping 8.3%, followed by shares of BETA Technologies Inc. Cl A, which dropped 7.3%. Shares of Lyntris Inc. dropped 6.8%, Evolution Metals & Technologies Corp. shares plunged 6.4%, and EverCommerce Inc. tumbled 6.2%.Major stock indexes in the U.S. closed up Tuesday with the Nasdaq Composite Index gaining 0.7%. Meanwhile, the S&P 500 Index increased 0.3%, and the Dow Jones Industrial Average added 0.3%.Data source: Dow ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABCL","BK4535","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662569607","title":"AbCellera rises 17.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662569607","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662569607?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:06","pubTimestamp":1787673965,"startTime":"0","endTime":"0","summary":"AbCellera (ABCL) is up 17.0%, or $1.80 to $12.41. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-rises-17-0-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-rises-17-0-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABCL","BK4121","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662200285","title":"Major Insider Move Signals Growing Confidence in AbCellera Biologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2662200285","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662200285?lang=en_us&edition=fundamental","pubTime":"2026-08-25 10:08","pubTimestamp":1787623726,"startTime":"0","endTime":"0","summary":"New insider activity at AbCellera Biologics ( ($ABCL) ) has taken place on August 24, 2026. Director Michael R. Hayden has demonstrated confidence ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-signals-growing-confidence-in-abcellera-biologics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-signals-growing-confidence-in-abcellera-biologics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABCL","BK4535","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662527209","title":"Abcellera Director Michael R. Hayden Reports $570,442 Common Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2662527209","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662527209?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:22","pubTimestamp":1787606551,"startTime":"0","endTime":"0","summary":"Abcellera director Michael R. Hayden reports $570,442 common share purchaseAbCellera Biologics director Hayden Michael R Hayden reported a purchase of 53,613 common shares at USD 10.64.Indirect holdin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLZ9w7w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Abcellera Director Michael R. Hayden Reports $570,442 Common Share Purchase","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4121","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473594","title":"AbCellera Biologics call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473594?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:50","pubTimestamp":1787169018,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in AbCellera (ABCL) Biologics with 17,987 calls trading, 2x expected, and implied vol increasing almost 6 points to 95...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-biologics-call-volume-above-normal-and-directionally-bullish-thefly-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-biologics-call-volume-above-normal-and-directionally-bullish-thefly-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","ABCL","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660416609","title":"Insider Confidence Surge: Director Makes Bold Move on AbCellera Biologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2660416609","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660416609?lang=en_us&edition=fundamental","pubTime":"2026-08-19 10:01","pubTimestamp":1787104919,"startTime":"0","endTime":"0","summary":"New insider activity at AbCellera Biologics ( ($ABCL) ) has taken place on August 18, 2026. Director John S. Montalbano has demonstrated confidence...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-confidence-surge-director-makes-bold-move-on-abcellera-biologics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-confidence-surge-director-makes-bold-move-on-abcellera-biologics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","ABCL","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491973","title":"Abcellera Director John S. Montalbano Acquires Common Shares Worth $110,300","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491973","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660491973?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:45","pubTimestamp":1787078757,"startTime":"0","endTime":"0","summary":"Abcellera director John S. Montalbano acquires common shares worth $110,300AbCellera Biologics director John S. Montalbano bought 10,000 common shares at $11.03.Direct holdings rose to 251,000 common ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL1T3hZy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU0353189680.USD","ABCL","LU0353189763.USD","LU2087625088.SGD","BK4535","PZZA","BK4209","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660464189","title":"AbCellera Biologics (ABCL) Gets a Buy from BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2660464189","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660464189?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:37","pubTimestamp":1787053054,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on AbCellera Biologics, with a price target of $15.00. The ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/abcellera-biologics-abcl-gets-a-buy-from-bmo-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/abcellera-biologics-abcl-gets-a-buy-from-bmo-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","BK4121","ABCL","BK4535","BMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659286231","title":"Abcellera Director Michael R Hayden Reports Purchase of Common Shares Worth $481,234.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2659286231","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659286231?lang=en_us&edition=fundamental","pubTime":"2026-08-14 23:50","pubTimestamp":1786722652,"startTime":"0","endTime":"0","summary":"Abcellera director Michael R Hayden reports purchase of common shares worth $481,234.19AbCellera Biologics director Hayden Michael R Hayden reported an indirect purchase of 46,387 common shares at USD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL7djph4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Abcellera Director Michael R Hayden Reports Purchase of Common Shares Worth $481,234.19","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4121","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659119166","title":"U.S. Stocks on the MOVE-EnerSys, Netflix, Salesforce","url":"https://stock-news.laohu8.com/highlight/detail?id=2659119166","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659119166?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:18","pubTimestamp":1786637899,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-EnerSys, Netflix, SalesforceAugust 13 (Reuters)-The S&P 500 hit an intraday record high on Thursday, boosted by technology stocks, as a drop in crude prices lifted risk ap","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL6N44A14N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSGS","DERM","BIRK","LUNL","STUB","CRMD","LNSR","CSCL","SPCE","LUNR","IBM","DKL","GLNG","NEM","DIOD","CSCS","TRUM","AVAH","OPEN","OMER","ABCL","AKAM","PYXS","DIPR","CBRS","ENS","CGEM","ABEO","ARX","DELL","RKLB","CRM","FIVE","TPR","XLC","NFLX","CSCO","LWAY","OTLK","STAA","MH","HLIT","HPQ","RKLX","AGMI","LESL","WSPC","WQTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659542721","title":"AbCellera Dips After $200 Mln Share Sale for Menopause Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2659542721","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659542721?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:28","pubTimestamp":1786624108,"startTime":"0","endTime":"0","summary":"BUZZ-AbCellera dips after $200 mln share sale for menopause drug** Shares of AbCellera BiologicsABCL.Odown 1.3% at $10.22 premarket on Thurs after $200 mln follow-on priced** Canadian biotech early Th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL6N44A0T4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001226.SGD","ABCL","BK0183","BK0015","SG9999001069.SGD","LU1064130708.USD","BK0188","BK0278","SGXZ90724238.SGD","LU1064131003.USD","BK0175","601288","SG9999001051.SGD","LU1497734951.SGD","LU1522347837.USD","LU2328871848.SGD","LU2148510915.USD","BK0012","LU1328615791.USD","BK4127","BK0028","SG9999006597.SGD","LU1634259391.SGD","JEF","LU1969619763.USD","BK0187","LU1634259557.SGD","LU1497733557.USD","BK4535","BK4121","LU1497733631.SGD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659804351","title":"AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2659804351","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659804351?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:06","pubTimestamp":1786593976,"startTime":"0","endTime":"0","summary":"BRIEF-AbCellera Announces Pricing Of Oversubscribed $200 Million Public Offering Of Common SharesAug 13 (Reuters)-AbCellera Biologics Inc.ABCL.O:ABCELLERA ANNOUNCES PRICING OF OVERSUBSCRIBED $200 MILL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN4491G9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABCL","BK4535","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659180483","title":"AbCellera Prices Oversubscribed Public Offering at USD 9.75 Per Share to Raise USD 200 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659180483","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659180483?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:05","pubTimestamp":1786593916,"startTime":"0","endTime":"0","summary":"AbCellera prices oversubscribed public offering at USD 9.75 per share to raise USD 200 millionAbCellera priced an oversubscribed underwritten public offering expected to raise about USD 200 million in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL6k6SSs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABCL","BK4121","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659801771","title":"Abcellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2659801771","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659801771?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:05","pubTimestamp":1786593910,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN4491G9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ABCL","BK4535"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abcellera.com","stockEarnings":[{"period":"1week","weight":0.1598},{"period":"1month","weight":0.0516},{"period":"3month","weight":1.2839},{"period":"6month","weight":2.7147},{"period":"1year","weight":1.6758},{"period":"ytd","weight":2.693}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0096},{"period":"3month","weight":0.02},{"period":"6month","weight":0.1744},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.117}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company; and a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.002724},{"month":2,"riseRate":0,"avgChangeRate":-0.119779},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.059327},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.055905},{"month":5,"riseRate":0.666667,"avgChangeRate":0.054331},{"month":6,"riseRate":0.5,"avgChangeRate":0.144975},{"month":7,"riseRate":0.5,"avgChangeRate":-0.006532},{"month":8,"riseRate":0.5,"avgChangeRate":0.100971},{"month":9,"riseRate":0.666667,"avgChangeRate":0.047249},{"month":10,"riseRate":0.6,"avgChangeRate":0.00539},{"month":11,"riseRate":0.6,"avgChangeRate":-0.007841},{"month":12,"riseRate":0.2,"avgChangeRate":-0.030878}],"exchange":"NASDAQ","name":"AbCellera Biologics","nameEN":"AbCellera Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AbCellera Biologics(ABCL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest AbCellera Biologics(ABCL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"AbCellera Biologics,ABCL,AbCellera Biologics股票,AbCellera Biologics股票老虎,AbCellera Biologics股票老虎国际,AbCellera Biologics行情,AbCellera Biologics股票行情,AbCellera Biologics股价,AbCellera Biologics股市,AbCellera Biologics股票价格,AbCellera Biologics股票交易,AbCellera Biologics股票购买,AbCellera Biologics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AbCellera Biologics(ABCL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest AbCellera Biologics(ABCL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}